Clinical Trials in Tennessee

Showing 15001-15020 of 20,239 trials

Effect of Prolonged PDE-5 Inhibition on Insulin Signaling in Skeletal Muscle.

NCT02129725

Our research proposal will determine if PDE-5 inhibition exerts a favorable effect on insulin signaling pathways in skeletal muscle of subjects with impaired fasting glucose and/or impaired glucose tolerance.

Metabolic Syndrome

Vanderbilt University Medical Center15 participantsStarted Apr 2014

Nashville, Tennessee, United States

COMPLETEDNA29 miles

Quantifying Abnormalities in Cortical Activation Associated With Auditory Hallucinations Using Functional Magnetic Resonance Imaging

NCT00288340

The goal of the project is to characterize abnormalities in brain structure and function related to schizophrenia. The investigators will use advanced magnetic resonance imaging (MRI) techniques to measure the degree and distribution of neuronal activity during specific cognitive tasks, alterations in neuronal connectivity, and how these are related to disease symptoms and treatment.

SchizophreniaSchizoaffective DisorderHallucinations

Vanderbilt University60 participantsStarted Jan 2006

Nashville, Tennessee, United States

TERMINATEDPhase 429 miles

Renin-Angiotensin and Fibrinolysis in Humans: Effect of Long-Term PDE5 Inhibition on Glucose Homeostasis

NCT01409993

The purpose of this study is to determine the effect of chronic PDE5 inhibitor therapy on glucose metabolism in persons with prediabetes.

Impaired Glucose Tolerance

Vanderbilt University78 participantsStarted Aug 2011

Nashville, Tennessee, United States

Effect of Prolonged PDE-5 Inhibition on Insulin Signaling in Skeletal Muscle.

Quantifying Abnormalities in Cortical Activation Associated With Auditory Hallucinations Using Functional Magnetic Resonance Imaging

Renin-Angiotensin and Fibrinolysis in Humans: Effect of Long-Term PDE5 Inhibition on Glucose Homeostasis

Find Trials by Condition in Tennessee

Characteristics of Glargine in Type 2 Diabetics

An Expanded Access, Open-Label Study of Obinutuzumab (GA101) Plus Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia

EXTEND (Eltrombopag Extended Dosing Study)

Dose Range Study of Anamorelin in Patients With Non-small Cell Lung Cancer

Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With Emphysema

Pediatric Schizophrenia Efficacy and Safety Study

AN2728 Topical Ointment to Treat Mild-to-Moderate Plaque-Type Psoriasis

Study of Nifedipine GITS and Candesartan Combination Compared to Monotherapy in Patients With Essential Hypertension

Salivary Diagnostic Testing for IVF

Thiazolidinedione Intervention With Vitamin D Evaluation

Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes

Rituximab and Denileukin Diftitox in Treating Patients With Previously Untreated Stage III or Stage IV Follicular B-Cell Non-Hodgkin's Lymphoma

Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer

Trastuzumab in Treating Patients With Advanced Salivary Gland Cancer

Safety, Tolerability, Pharmacokinetics, and Immunoregulatory Study of Urelumab (BMS-663513) in Subjects With Advanced and/or Metastatic Solid Tumors and Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma

Efficacy and Safety of Lixisenatide Versus Placebo on Top of Basal Insulin and/or Oral Antidiabetic Treatment in Older Type 2 Diabetic Patients

Capecitabine and Vorinostat in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer